(Circulation. 2000;102:771.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From Dipartimento di Medicina Clinica e Sperimentale (P.P., M.P., E.F., N.S., V.P., S.D.R., M.Z., A.C.P.), Chirurgia Vascolare I (G.P.D., F.G.), Laboratorio di Analisi (M.P.), Dipartimento di Scienze Biomediche (S.S.), Università degli Studi di Padova (Italy); Centro Regionale dellAterosclerosi (G.B.B.), Venezia, Italy; and INSERM U 127 (C.H., J.-L.S.), Hôpital Lariboisiere, Paris, France.
Correspondence to Prof Paolo Pauletto, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Padova, Via Giustiniani, 2-35128 Padova, Italy. E-mail pauletto{at}ux1.unipd.it
| Abstract |
|---|
|
|
|---|
Methods and ResultsOne hundred fifty patients were studied.
Endarterectomy specimens were tested by
immunocytochemistry with the use of (1) monoclonal antibodies that
identify smooth muscle cells (SMCs) and fetal-type SMCs on the basis of
smooth muscle and nonmuscle myosin content, (2) the
anti-macrophage HAM 56, and (3) the anti-lymphocyte CD45RO. The
maximum intima-media thickness (M-IMT) of the revascularized vessel was
assessed by the use of B-mode ultrasonography 6 months after surgery.
The M-IMT values were related positively to the number of SMCs
(r=0.534, P<0.0005) and negatively to
that of macrophages and lymphocytes (r=-0.428,
P<0.0005, and -0.538, P=0.001,
respectively). Patients were classified as class 1 (M-IMT
1.0
mm), class 2 (1.0<M-IMT
1.3 mm), and class 3 (M-IMT >1.3
mm). An abundance of SMCs, mostly of fetal type, was found in the
plaque of class 3 patients, whereas lesions from class 1 patients were
rich in macrophages and lymphocytes. In the
multivariate analysis, factors related to M-IMT
were the number of SMCs and the percentage of fetal-type SMCs
present in the plaque.
ConclusionsAlthough the classic risk factors did not play a role, an abundance of SMCs and a scarcity of macrophages characterized the primary lesion of patients in whom neointima developed after surgery. In patients in whom neointima did not develop, lesions were rich in macrophages and lymphocytes. This approach can be useful in defining patients at risk of restenosis.
Key Words: atherosclerosis restenosis carotid arteries muscle, smooth lymphocytes
| Introduction |
|---|
|
|
|---|
The in vivo follow-up of neointima development by high-resolution ultrasound technique, combined with the study of cell composition of the endarterectomy tissue retrieved at carotid surgery, can furnish new information on the importance of primary atherosclerotic lesion to be predictive of restenosis. Although hemodynamically significant narrowing caused by neointima is not often observed after carotid endarterectomy, all patients undergo long-term ultrasound follow-up to rule out this possibility. The identification of those prone to the development of neointima after surgery could therefore be useful in avoiding unnecessary follow-up procedures and in concentrating on patients at risk. Moreover, this approach may contribute to a better understanding of the process itself.
The aim of the Carotid Atherosclerosis and Restenosis Study (CARS) was the following: (1) to establish the degree of carotid intima-media thickness (IMT) developed after carotid endarterectomy in patients who had undergone this procedure for significant carotid narrowing, (2) to evaluate the cell composition and the SMC phenotype in the primary lesion of patients who have a different degree of IMT at follow-up, and (3) to compare the characteristics of the primary lesion with those of the restenosis lesion.
| Methods |
|---|
|
|
|---|
70%. Most patients had previous signs or symptoms of
cerebrovascular disease. Before surgery, anthropometric and anamnestic
data, including those from standard biochemical blood analyses,
were collected. Plasma levels of Lp(a), homocysteine, minimally
modified LDL, and MDA-LDL were also evaluated according to previously
published methods.11 12 13 As an established procedure, the endarterectomy was coupled with a PTFE patch. The specimens of primary lesion retrieved at surgery were immediately placed in an OCT compound, frozen in liquid nitrogen, and stored at -80°C.
The study was approved by the local ethics committee. All patients gave informed consent.
Ultrasound Follow-Up
An ultrasound examination of the supra-aortic trunks was
instituted by 6 months after surgery with the use of the Biosound
2000/II/SA (Esaote Biomedica), equipped with an 8-MHz annular array
mechanical transducer. This system provides an axial resolution of
0.10 mm.14 All subjects were examined in the same
room, in dim light, lying comfortably in a supine position. Once an
optimal longitudinal image was obtained, it was stored on half-inch
super-VHS videotape. Images were analyzed by an independent
reader, using a high-resolution video recorder (Panasonic AG-7355)
coupled with a mouse-driven image analysis system (AMS VIDS V).
IMT, defined as the distance between the lumen-intima and the
media-adventitia interfaces, was measured at end-diastole
in the far wall, as previously described.15 The maximum
IMT (M-IMT) was assessed in the carotid artery segment subjected to
endarterectomy.
According to current ultrasonographic criteria,16 17
patients were classified at follow-up into 3 different classes as
normal (M-IMT
1.0 mm, class 1), intermediate (1.0< M-IMT
1.3 mm, class 2), and plaque (M-IMT >1.3 mm, class 3).
Immunocytochemistry and Image Analysis
Seventy-four optimally preserved specimens without extensive
fissuring or disruption of the plaque and the underlying media, where
present, were analyzed. The cell composition
analysis was carried out in a randomly chosen block of tissue.
From each block, 8 seriate sections taken at 8-µm intervals were
analyzed. The following monoclonal antibodies were used: SM-E7
antismooth muscle (SM)myosin heavy chains (MyHC), NM-F6
antiNM-MyHC, HAM 56 antimonocyte-macrophage (gift of R.
Ross and E. Reines), and CD45RO anti-lymphocyte (Dako, Dakopatts). The
SM-E7 reacts with SM-type MyHC (both SM1 and SM2)
exclusively.18 The NM-F6 is able to identify a specific
antigenic epitope localized in the platelet-type MyHC isoforms
MyHC-Apla1 and reacts neither with B-type NM-MyHC
nor SM-MyHC.18 The combined use of SM-E7 and NM-F6
antibodies allows the identification of fetal-type SMCs, whereas SM-E7
alone identifies the whole SMC population. Primary antibodies (except
for CD45RO) were applied to the freshly cut unfixed cryosection (8
µm), as previously described.4 Nuclei were revealed with
the use of the bis-benzimide stain (Hoechst 33258). Sections
were examined with a Zeiss Axioplan microscope equipped with a
Hammamatsu CCD high-resolution camera with a x40 Planapo objective
lens. The assessment of the different cell types was carried out by the
same observer, who was unaware of the outcome of the ultrasound
follow-up.
For cell count, we considered 3 standard areas (70 µm2) of the plaque: the basal, the shoulder, and the cap regions. In 65% of the specimens, it was possible to clearly distinguish and analyze some of the media layer underneath the plaque. In these cases, 3 random fields (70 µm2) were considered. We evaluated the size of each cell population by assessing on seriate cryosections the number of cells per area unit positive to SM-E7, HAM 56, or CD45RO, respectively. Moreover, the relative prevalence of each cell type was calculated as the percentage of positive cells to the total number of nuclei per area. Since macrophages and lymphocytes in the plaque contain A-type NM-MyHC, the assessment of fetal-type SMCs (expressing MyHC-Apla1 along with SM-MyHC) was carried out in areas where SMCs were largely predominant with the use of seriate cryosections stained by the NM-F6 and the SM-E7 antibodies. Because macrophages and/or lymphocytes were not found in the media layer underneath the plaque, cells identified by the NM-F6 correspond to fetal-type SMCs inasmuch as all cells in this layer are labeled with the SM-E7. The prevalence of fetal-type SMCs was expressed as a percentage of total SMCs.
To ascertain the reproducibility of the assessment of the various cell types, 3 standard sites were selected in 8 randomly chosen endarterectomy specimens: (1) distal (cranially), (2) intermediate, and (3) distal (caudally). The length of specimens ranged between 0.5 and 2.6 cm. In the 3 sites, seriate cryosections were cut at 8-µm intervals and processed for immunocytochemistry for SMCs, macrophages, and lymphocytes, respectively. Variability in cell counts obtained from the 3 sites was assessed for each cell type by the use of (1) ANOVA for repeated measurements within subjects (ie, specimens) and (2) the coefficient of variation of the mean difference of repeated measurements. No difference between repeated assessments of SMCs (F=2.482, P=0.120), macrophages (F=0.225, P=0.801), and lymphocytes (F=1.298, P=0.304) was found by ANOVA. The coefficient of variation was 5.3% for SMCs, 4.8% for macrophage, and 3.4% for lymphocyte measurements.
Statistical Analysis
Continuous variables were averaged, expressed as mean±SD,
and compared by means of ANOVA and Bonferronis correction.
Prevalences of categoric variables were evaluated with 2-way
contingency tables, expressed as percentage rate, and compared by means
of the Pearson
2 test. The
univariate correlation between M-IMT and other continuous
variables was evaluated by Pearson correlation coefficient with
Bonferronis adjusted probabilities. M-IMT was also played into a
multiple regression analysis, obtaining 1 multiple correlation
coefficient (r). Class of IMT was played as a categoric
variable into a logistic regression analysis. The SYSTAT
package was used for this purpose.
| Results |
|---|
|
|
|---|
|
In the subset of patients in which minimally modified LDL and MDA-LDL were tested, the distribution of MDA-LDL did not change according to the class. Conversely, higher values of minimally modified LDL (expressed as % of total LDL) were found in class 1 compared with class 3 patients (6.32±1.76, n=13, versus 4.58±2.23, n=20, P=0.024), and an inverse relation between levels of these lipoproteins and M-IMT was present in the whole population (r=-0.397, P=0.018).
Cell Composition of Primary Lesion and Restenosis Tissue
As shown in Figure 1
, the primary
lesions retrieved at surgery from patients who subsequently had an
M-IMT value >1.3 mm at ultrasound follow-up (class 3) displayed
an abundance of SMCs, mostly of the fetal type (Figure 1
, B and
D), compared with lesions from patients who had the lower level of
M-IMT at follow-up (class 1, Figure 1
, A and C). Moreover, in
lesions from class 3 patients, the media layer underneath the plaque
appeared to be poorer in SMCs than in lesions from class 1 patients
(Figure 1
, E and F). In either case, the labeling of medial SMCs
with the SM-E7 and the NM-F6 was present, indicating coexpression
of SM-MyHC and NM-MyHC-Apla1, which characterizes
the fetal-type SMCs. Another relevant feature was that
macrophages and lymphocytes were less abundant in primary
lesions from class 3 patients compared with class 1 (Figure 2
).
|
|
In 4 class 3 patients (2.6% of the series),
hemodynamically significant carotid artery
restenosis occurred within the 6-month follow-up period. When a
new endarterectomy was performed, the
restenosis tissue displayed a cell composition very close to
that of the primary lesion of class 3 patients, namely, an abundance of
fetal-type SMCs and scattered macrophages and lymphocytes
(Figure 3
).
|
Relation Between M-IMT at Follow-Up and Cell Composition
of the Primary Lesion
The immunocytochemistry-based assessment of cells present in
both medial and intimal layers of the different classes is reported in
Table 2
.
|
A higher number of SMCs was found in the plaque of class 3 patients
compared with the other classes, class 1 in particular. Most SMCs were
of the fetal type (also see Figure 1
). Conversely, lesions from
class 1 patients displayed a strikingly higher number of
macrophages and lymphocytes than those from class 2 patients,
and even more so when compared with class 3 patients.
In the tunica media underneath the plaque, a reduced number of SMCs was found in class 3 and 2 patients compared with class 1. A significantly higher percentage of fetal-type medial SMCs was also found in specimens from class 3 compared with class 1.
In the whole population, individual values of carotid M-IMT at
follow-up were played against the cell types found in the plaque and
media of the endarterectomy specimen by
univariate (Table 3
) or
multivariate (Table 4
) analysis. In the
plaque, M-IMT was related positively to SMCs (irrespective of the
differentiation pattern) and negatively to macrophages and
lymphocytes. In the media, values of M-IMT were related negatively to
SMCs and positively to fetal-type SMCs (Table 3
). However, when
all data from the population (including risk factors and anthropometric
data) were played in the multivariate regression
analysis, the only factors related to M-IMT were the number of
SMCs and the percentage of fetal-type SMCs in the plaque (Table 4
). The role of these factors was confirmed at the logistic
regression analysis (not shown). Moreover, in this latter
analysis, the number of macrophages present in the
plaque (class 3 versus class 1 as reference) was a negative predictor
of M-IMT at follow-up (P<0.0005, OR 0.210, 95% CI 0.500 to
0.089).
|
|
| Discussion |
|---|
|
|
|---|
50% of patients had >1.3-mm M-IMT and only 23% had a value
1.0 mm. Hence, a relevant increase in IMT had taken place in the
majority of patients, although the incidence of
hemodynamically significant restenosis was only
2.6% and surgery was optimally carried out. As expected from previous
reports,1 2 a significant relation between risk factors
and the increase in neointima was not observed in our
sample. This was true even for "new" risk factors such as
homocysteine, Lp(a), minimally modified LDL, and MDA-LDL, which were
not tested before in this setting. Instead, the analysis of the
primary lesions retrieved at surgery, in particular those from class 3
and 1 patients, offered some insights into the process of
neointima formation. Atherosclerotic plaques from patients of class 3 displayed an abundance of SMCs compared with lesions from patients of class 1. Moreover, the media layer underneath the plaque showed a reduced number of SMCs in specimens from class 3 patients compared with those from class 1. Another relevant feature was that macrophages and lymphocytes were less numerous in primary lesions from class 3 patients compared with class 1 patients. When the restenosis tissue was analyzed, it displayed a cell composition very close to that of primary lesions of class 3 patients, with an abundance of SMCs and a few scattered macrophages and lymphocytes. The reliability of cell counts was endorsed by the survey specifically done, for example, the low coefficients of variation and the nonsignificant difference in measurements with the use of repeated-measures analysis. For each cell type, the difference in cell number among the 3 classes was too large to be explained by intrinsic variability within a specimen or by counting bias.
The individual value of carotid M-IMT at follow-up was then played against the cell types found in the plaque and media of the endarterectomy specimen. In the plaque, the M-IMT value of the whole population was related positively to SMCs (mostly of the fetal type), whereas there was a negative correlation with macrophages and lymphocytes. In the media, the M-IMT value was related negatively to the SMC number and positively to the percentage of fetal-type SMCs. The relation between M-IMT and these cell types was also confirmed by multivariate and logistic regression analyses.
The decreased number of SMCs observed in the media underneath the atheroma of class 3 patients, along with the prevalence of the fetal phenotype, suggests that these cells have the ability to migrate and accumulate in the intima after revascularization. This hypothesis is strongly supported by the finding that (1) both medial and intimal SMCs displayed a fetal-type pattern of differentiation, and (2) fetal-type SMCs are prevalent in the primary atheroma, well before the process leading to cell accumulation in the intima has started. The acquisition of this cell phenotype is the hallmark of atherosclerosis and neointima formation in experimental models as well as in human pathology.9 10 18 19 20 21 22 In these circumstances, NM-MyHC-Apla1 expression in SMCs (ie, a marker of fetal-type SMCs) is upregulated, resembling the pattern found at the early stages of development.9 18 19 It is of interest that class 3 primary and secondary lesions shared the same content of NM-MyHC-Apla1 in SMCs, in agreement with Nikol et al.9 Other studies have postulated that B-type NM-MyHC expression in SMCs from the primary lesion of coronary arteries is a predictive marker of restenosis after the revascularization procedure.7 8 In humans, however, this NM myosin isoform is not developmentally regulated as occurs, instead, with NM-MyHC-Apla119 and with the SM2 isoform of SM-MyHC,10 which is downregulated in both the atherosclerotic plaque and the restenosis tissue.
An accumulation of fewer intimal cells occurred when NM cells of the inflammatory type predominated in the primary lesion (class 1 patients). This suggests that macrophages and lipids play a role in the pathogenesis of atheroma but not in the neointima development, with its inherent SMC encroachment. In accordance with this hypothesis, in class 1 patients a higher level of minimally modified plasma LDL was found compared with class 3 patients, which was mirrored by an inverse relation between these lipoproteins and the level of M-IMT at follow-up. We speculate that the reduced cellularity in the atherosclerotic lesion of class 1 patients is due to a slowing down of the passage of medial SMCs to intima. Such a process also might be accompanied by a direct effect of macrophage-released cytokines and lipids on the SMC differentiation profile.21 22
In conclusion, this study shows for the first time that the tissue retrieved at carotid endarterectomy displays some peculiar cellular and molecular features that might be useful for the identification of patients at risk of the development of restenosis. Of course, our data are retrospective and need to be confirmed in the multicenter, prospective part of the CARS, which will be aimed at defining the cellular threshold for high or low risk of neointima formation. This would permit the possibility of selecting patients who need to be followed up very closely over those who do not, with obvious advantages in terms of saving time and money.
| Acknowledgments |
|---|
Received December 31, 1999; revision received March 10, 2000; accepted March 10, 2000.
| References |
|---|
|
|
|---|
2.
Rensing BJ, Hermans WR, Vos J, et al. Luminal
narrowing after percutaneous transluminal
coronary angioplasty: a study of clinical, procedural, and
lesional factors related to long-term angiographic outcome: CARPORT
Study Group. Circulation. 1993;88:975985.
3.
Lafont A, Guzman LA, Whitlow PL, et al.
Restenosis after experimental angioplasty: intimal, medial, and
adventitial changes associated with constrictive remodeling. Circ
Res. 1995;76:9961002.
4.
Faggin E, Puato M, Zardo L, et al. Smooth
musclespecific SM22 protein is expressed in the adventitial cells of
balloon-injured rabbit carotid artery. Arterioscler Thromb Vasc
Biol. 1999;19:13931404.
5. Pauletto P, Sartore S, Pessina AC. Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. Clin Sci. 1994;87:467479.[Medline] [Order article via Infotrieve]
6.
Libby P, Ganz P. Restenosis revisited-new
targets, new therapies. N Engl J Med. 1997;337:418419. Editorial.
7.
Leclerc G, Isner JM, Kearney M, et al. Evidence
implicating nonmuscle myosin in restenosis: use of in situ
hybridization to analyze human vascular lesions obtained by
directional atherectomy. Circulation. 1992;85:543553.
8.
Simons M, Leclerc G, Safian RD, et al. Relation
between activated smooth-muscle cells in
coronary-artery lesions and restenosis after
atherectomy. N Engl J Med. 1993;328:608613.
9. Nikol S, Murakami N, Pickering G, et al. Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque. Atherosclerosis. 1997;130:7185.[Medline] [Order article via Infotrieve]
10.
Aikawa M, Sakomura Y, Ueda M, et al. Redifferentiation
of smooth muscle cells after coronary angioplasty determined
via myosin heavy chain expression. Circulation. 1997;96:8290.
11. Kostner GM, Gries A, Pometta M, et al. Immunochemical determination of lipoprotein Lp(a): comparison of Laurell electrophoresis and ELISA. Clin Chim Acta. 1990;188:187192.[Medline] [Order article via Infotrieve]
12.
Shipchandler MT, Moore EG. Rapid, fully automated
measurement of plasma homocysteine with the Abbott Imx
Analyzer. Clin Chem. 1995;41:991994.
13. Sevanian A, Bittolo Bon G, Cazzolato G, et al. LDL is a lipid hydroperoxide-enriched circulating lipoprotein. J Lipid Res. 1997;38:419428.[Abstract]
14.
Howard G, Sharrett AR, Heiss G, et al. Carotid artery
intimal-medial thickness distribution in general populations as
evaluated by B-mode ultrasound: ARIC Investigators. Stroke. 1993;24:12971304.
15.
Pauletto P, Palatini P, Da Ros S, et al. Factors
underlying the increase un carotid intima-media thickness in borderline
hypertensives. Arterioscler Thromb Vasc Biol. 1999;19:12311237.
16.
Prisant LM, Zemel PC, Nichols FT, et al. Carotid plaque
associations among hypertensive patients. Arch Intern Med. 1993;153:501506.
17. Mercuri M, Devi K. Quantitative ultrasonographic evaluation of the carotid arteries in hypertension. J Cardiovasc Risk. 1995;2:2733.[Medline] [Order article via Infotrieve]
18.
Sartore S, Chiavegato A, Faggin E, et al. Myosin gene
expression and cell phenotypes in vascular smooth muscle during
development, in experimental models, and in vascular disease.
Arterioscler Thromb Vasc Biol. 1997;17:12101215.
19. Frid MG, Printseva OY, Chiavegato A, et al. Myosin heavy chain isoform composition and distribution in developing and adult aortic smooth muscle. J Vasc Res. 1993;30:279292.[Medline] [Order article via Infotrieve]
20.
Aikawa M, Nalla Sivam P, Kuro-o M, et al. Human smooth
muscle myosin heavy chain isoforms as molecular markers for vascular
development and atherosclerosis. Circ Res. 1993;73:10001012.
21.
Aikawa M, Rabkin E, Voglic SJ, et al. Lipid lowering
promotes accumulation of mature smooth muscle cells expressing smooth
muscle myosin heavy chain isoforms in rabbit atheroma.
Circ Res. 1998;83:10151026.
22. Fukumoto Y, Shimokawa H, Ito A, et al. Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. J Cardiovasc Pharmacol. 1997;29:222231.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
N. Makihara, K. Toyoda, K. Uda, T. Inoue, S. Gotoh, S. Fujimoto, K. Yasumori, S. Ibayashi, M. Iida, and Y. Okada Characteristic Sonographic Findings of Early Restenosis After Carotid Endarterectomy J. Ultrasound Med., September 1, 2008; 27(9): 1345 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Proctor, X. Jin, T. S. Lupu, L. J. Muglia, C. F. Semenkovich, and A. J. Muslin Requirement for p38 Mitogen-Activated Protein Kinase Activity in Neointima Formation After Vascular Injury Circulation, August 5, 2008; 118(6): 658 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Puato, E. Faggin, E. Favaretto, B. Bertipaglia, M. Rattazzi, D. Rizzoni, G. P. Gamba, S. Sartore, E. A. Rosei, A. C. Pessina, et al. Prevalence of Fetal-Type Smooth Muscle Cells in the Media of Microvessels From Hypertensive Patients Hypertension, August 1, 2004; 44(2): 191 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, J. Ren, M. F. Khan, A. M. Cheng, D. Abendschein, and A. J. Muslin Grb2 Is Required for the Development of Neointima in Response to Vascular Injury Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1788 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Faggin, A. Zambon, M. Puato, S. S. Deeb, S. Bertocco, S. Sartore, G. Crepaldi, A. C. Pessina, and P. Pauletto Association between the -514 c->t polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Kuhel, B. Zhu, D. P. Witte, and D. Y. Hui Distinction in Genetic Determinants for Injury-Induced Neointimal Hyperplasia and Diet-Induced Atherosclerosis in Inbred Mice Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 955 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Meraviglia, E. Maggi, G. Bellomo, M. Cursi, G. Fanelli, and F. Minicucci Autoantibodies Against Oxidatively Modified Lipoproteins and Progression of Carotid Restenosis After Carotid Endarterectomy Stroke, April 1, 2002; 33(4): 1139 - 1141. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |